| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 87 |
| 1 | SITAGLIPTIN | 47 |
| 2 | OLANZAPINE PAMOATE | 41 |
| 3 | INSULIN GLARGINE | 35 |
| 4 | LISINOPRIL | 33 |
| 5 | ATORVASTATIN CALCIUM | 31 |
| 6 | ARIPIPRAZOLE | 30 |
| 7 | ASPIRIN | 30 |
| 8 | ASPIRIN 325 MG | 30 |
| 9 | ASPIRIN 81 MG | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETRAVIRINE | 5 | 0.0011 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 3 | 0.0011 |
| 2 | OLANZAPINE PAMOATE | 41 | 0.0010 |
| 3 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 19 | 0.0009 |
| 4 | LITHIUM CARBONATE | 14 | 0.0008 |
| 5 | SITAGLIPTIN | 47 | 0.0006 |
| 6 | BENAZEPRIL HYDROCHLORIDE | 4 | 0.0005 |
| 7 | EZETIMIBE AND SIMVASTATIN | 8 | 0.0005 |
| 8 | GEMFIBROZIL | 6 | 0.0005 |
| 9 | QUETIAPINE | 87 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 77 |
| 1 | Insulin Analog [EPC] | 61 |
| 2 | Benzodiazepine [EPC] | 56 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 44 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 32 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 31 |
| 6 | Corticosteroid [EPC] | 26 |
| 7 | Loop Diuretic [EPC] | 25 |
| 8 | GLP-1 Receptor Agonist [EPC] | 24 |
| 9 | Sulfonylurea [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 3 | Insulin [EPC] | 13 | 0.0003 |
| 4 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 7 | Anti-anginal [EPC] | 2 | 0.0002 |
| 8 | Sulfonylurea [EPC] | 22 | 0.0002 |
| 9 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 10 | 0.0002 |